Erschienen in:
01.10.2013 | Genetics
The association between thrombophilic gene mutations and recurrent pregnancy loss
verfasst von:
Ahmad Poursadegh Zonouzi, Nader Chaparzadeh, Saeid Ghorbian, Mahzad Mehrzad Sadaghiani, Laya Farzadi, Alieh Ghasemzadeh, Taiebeh Kafshdooz, Masoud Sakhinia, Ebrahim Sakhinia
Erschienen in:
Journal of Assisted Reproduction and Genetics
|
Ausgabe 10/2013
Einloggen, um Zugang zu erhalten
Abstract
Purpose
To determine whether the Factor V (1691G/A), Factor V HR2 (4070A/G), Prothrombin (20210G/A), PAI-1 (-675 I/D, 5G/4G), ACE (intron 16 I/D), Factor VII (Gln353Arg), Factor XIII (Val34Leu), β-fibrinogen (-455G/A), Glycoprotein Ia (807C/T), tPA (intron 8 D/I) gene mutations could be risk factors for recurrent pregnancy loss (RPL).
Methods
Genotyping of thrombophilic gene mutations were carried out by amplification Refractory Mutation System-PCR (ARMS-PCR) method after DNA extraction.
Results
We found that the mutant allele frequencies of Factor V (1691G/A), Factor V HR2 (4070A/G), Prothrombin (20210G/A), PAI-1 (-675 I/D, 5G/4G), Factor XIII (Val34Leu) and β-fibrinogen (-455G/A) were more seen in the case group compared with the healthy control; However, the difference between the two group is not statistically significant (p > 0.05). Whilst the mutant allele frequencies of other studied genes were lower in the case in comparison to the fertile control women (p > 0.05).
Conclusion
Taken together, our data has shown that the prevalence of thrombophilic gene mutations was similar in women with RPL and healthy controls. Therefore, it appears that further studies on large-scale population and other genetic variants will be needed to conclusively find candidate genes for RPL unknown etiology in the future.